肺移植围术期处理

doi:10.3877/cma.j.issn.2096-1537.2018.02.019

肺移植术（LTX）是治疗终末期肺疾病的一种有益选择。由于我国供体肺紧缺以及大量终末期肺疾病患者没能及时进行肺移植评估，导致这些患者需要在重症医学科（ICU）内行生命支持的同时进行LTX等待及评估；而且这些患者的术后并发症也较多。这样ICU医生对肺移植受体围术期评估和支持能力面临着巨大的挑战。本文就在ICU内LTX受体的围术期管理，包括术前评估，术后并发症以及体外膜氧合（ECMO）技术的应用，根据国外的文献结合本中心的经验进行综述。

关键词: 肺移植, 围术期, 体外膜氧合

Lung transplantation (LTX) is an optimal therapy for end-stage of lung disease. Because of the shortage of donor lung and the failure of LTX assessment timely in patients with end-stage lung disease, a large number of LTX recipients have to receive the life supports and assessments of LTX in Intensive Care Unit (ICU). These recipients always have more postoperative complications. In this way, it is a great challenge for ICU physicians to deliver life support and assessment for the LTX recipients during the perioperation. In this review we will discuss the perioperative managements in ICU, including preoperative evaluation, postoperation complications management and the utility of extracorporeal membrane oxygenation (ECMO), based on the foreign literatures and the experience of our center.

Key words: Lung transplantation, Perioperation, Extracorporeal membrane oxygenation

[1]	Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis [J]. N Engl J Med, 1986, 314(18): 1140-1145.
[2]	Yusen RD,Edwards LB,Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report—2014, focus theme: retransplantation [J]. J Heart Lung Transplant, 2014, 33(10): 1009-1024.
[3]	黄剑伟,龙小毛. 肺移植供肺保护研究进展[J/CD].实用器官移植电子杂志, 2014, 2(2): 117-119.
[4]	陈静瑜. 肺移植供体肺的维护及获取 [J]. 武汉大学学报(医学版), 2016, 37(4): 540-542.
[5]	Yusen RD,Christie JD,Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report—2013, focus theme: age [J]. J Heart Lung Transplant, 2013, 32(10): 965-978.
[6]	Jones RM,Enfield KB,Mehrad B, et al. Prevalence of obstructive coronary artery disease in patients undergoing lung transplantation: case series and review of the literature [J]. Catheter Cardiovasc Interv, 2014, 84(1): 1-6.
[7]	McKellar SH,Bowen ME,Baird BC, et al. Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant [J]. J Heart Lung Transplan, 2016, 35(11): 1289-1294.
[8]	Chaikriangkrai K,Jyothula S,Jhun HY, et al. Impact of preoperative coronary artery disease on cardiovascular events following lung transplantation [J]. J Heart Lung Transplant, 2016, 35(1): 115-121.
[9]	Koprivanac M,Budev MM,Yun JJ, et al. How important is coronary artery disease when considering lung transplant candidates? [J]. J Heart Lung Transplant, 2016, 35(12): 1453-1461.
[10]	Andersen KH,Schultz HH,Nyholm B, et al. Pulmonary hypertension as a risk factor of mortality after lung transplantation [J]. Clin Transplant, 2016, 30(4): 357-364.
[11]	Christie JD,Sager JS,Kimmel SE, et al. Impact of primary graft failure on outcomes following lung transplantation [J]. Chest, 2005, 127(1): 161-165.
[12]	Lee JC,Christie JD,Keshavjee S. Primary graft dysfunction: definition, risk factors, short- and long-term outcomes [J]. Semin Respir Crit Care Med, 2010, 31(2): 161-171.
[13]	López-Aguilar J,Piacentini E,Villagrá A, et al. Contributions of vascular flow and pulmonary capillary pressure to ventilator-induced lung injury [J]. Crit Care Med, 2006, 34(4): 1106-1112.
[14]	Pérez-Terán P,Roca O,Rodríguez-Palomares J, et al. Prospective validation of right ventricular role in primary graft dysfunction after lung transplantation [J]. Eur Respir J, 2016, 48(6): 1732-1742.
[15]	Shah PR,Boisen ML,Winger DG, et al. Extracorporeal support during bilateral sequential lung transplantation in patients with pulmonary hypertension: risk factors and outcomes [J]. J Cardiothorac Vasc Anesth, 2017, 31(2): 418-425.
[16]	Balcı MK,Arı E,Vayvada M, et al. Assessment of pulmonary hypertension in lung transplantation candidates: correlation of Doppler echocardiography with right heart catheterization [J]. Transplant Proc, 2016, 48(8): 2797-2802.
[17]	Mainz JG,Hentschel J,Schien C, et al. Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation [J]. J Cyst Fibros, 2012, 11(2): 158-161.
[18]	Hirche TO,Knoop C,Hebestreit H, et al. Practical guidelines: lung transplantation in patients with cystic fibrosis [J]. Pulm Med, 2014, 2014: 621342.
[19]	Gottlieb J,Mattner F,Weissbrodt H, et al. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis [J]. Respir Med, 2009, 103(5): 743-749.
[20]	Courtwright AM,Salomon S,Lehmann LS, et al. The association between mood, anxiety and adjustment disorders and hospitalization following lung transplantation [J]. Gen Hosp Psychiatry, 2016, 41(1): 1-5.
[21]	Jha SR,Hannu MK,Gore K, et al. Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation [J]. J Heart Lung Transplant, 2016, 35(9): 1092-1100.
[22]	Kelm DJ,Bonnes SL,Jensen MD, et al. Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation [J]. Clin Transplant, 2016, 30(3): 247-255.
[23]	Upala S,Panichsillapakit T,Wijarnpreecha K, et al. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta-analysis [J]. Transpl Int, 2016, 29(3): 285-296.
[24]	Sharma NS,Hartwig MG,Jr HD. Extracorporeal membrane oxygenation in the pre and post lung transplant period [J]. Ann Transl Med, 2017, 5(4): 74
[25]	Egan TM,Edwards LB. Effect of the lung allocation score on lung transplantation in the United States [J]. J Heart Lung Transplant, 2016, 35(4): 433-9.
[26]	Hoopes CW,Kukreja J,Golden J, et al. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation [J]. J Thorac Cardiovasc Surg, 2013, 145(3): 862-867.
[27]	Nazarnia S,Subramaniam K. Pro: veno-arterial extracorporeal membrane oxygenation (ECMO) should be used routinely for bilateral lung transplantation [J]. J Cardiothorac Vasc Anesth, 2017, 31(4): 1505-1508.
[28]	Yu WS,Paik HC,Haam SJ, et al. Transition to routine use of venoarterial extracorporeal oxygenation during lung transplantation could improve early outcomes [J]. J Thorac Dis, 2016, 8(7): 1712-1720.
[29]	Ius F,Sommer W,Tudorache I, et al. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: indications and midterm results [J]. J Heart Lung Transplant, 2016, 35(1): 49-58.
[30]	Glassman LR,Keenan RJ,Fabrizio MC, et al. Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients [J]. J Thorac Cardiovasc Surg, 1995, 110(3): 723-726.
[31]	Zenati M,Pham SM,Keenan RJ, et al. Extracorporeal membrane oxygenation for lung transplant recipients with primary severe donor lung dysfunction [J]. Transpl Int, 1996, 9(3): 227-230.
[32]	Pereszlenyi A,Lang G,Steltzer H, et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension [J]. Eur J Cardiothorac Surg, 2002, 21(5): 858-863.
[33]	Salman J,Ius F,Sommer W, et al. Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension [J]. Eur J Cardiothorac Surg, 2017, 52(1): 163-170.
[34]	Lam CP,Chow MP. HLA antibodies in multiple transfused patients [J]. Zhonghua Yi Xue Za Zhi (Taipei), 1992, 50(6): 439-442.
[35]	Hayes D Jr,Preston TJ,Kirkby S, et al. Human leukocyte antigen sensitization in lung transplant candidates supported by extracorporeal membrane oxygenation [J]. Am J Respir Crit Care Med, 2013, 188(5): 627-628.
[36]	Ong LP,Sachdeva A,Ramesh BC, et al. Lung transplant with cardiopulmonary bypass: impact of blood transfusion on rejection, function, and late mortality [J]. Ann Thorac Surg, 2016, 101(2): 512-519.
[37]	Ong LP,Thompson E,Sachdeva A, et al. Allogeneic blood transfusion in bilateral lung transplantation: impact on early function and mortality [J]. Eur J Cardiothorac Surg, 2016, 49(2): 668-674.
[38]	Hayes D Jr,Tumin D,Yates AR, et al. Transfusion with packed red blood cells while awaiting lung transplantation is associated with reduced survival after lung transplantation [J]. Clin Transplant, 2016, 30(12): 1545-1551.
[39]	Montefusco CM,Veith FJ. Lung transplantation [J]. Surg Clin North Am, 1986, 66(3): 503-515.
[40]	Lee JC,Christie JD. Primary graft dysfunction [J]. Clin Chest Med, 2011, 32(2): 279-293.
[41]	Bonser RS,Taylor R,Collett D, et al. Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry [J]. Lancet, 2012, 380(9843): 747-755.
[42]	Diamond JM,Lee JC,Kawut SM, et al, Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation [J]. Am J Respir Crit Care Med, 2013, 187(5): 527-534.
[43]	Christie JD,Carby M,Bag R, et al. ISHLT Working Group on primary lung graft dysfunction. Report of the ISHLT Working Group on primary lung graft dysfunction part Ⅱ: definition. A consensus statement of the international society for heart and lung transplantation [J]. J Heart Lung Transplant, 2005, 24(10): 1454-1459.
[44]	Júnior AJE,Campos W E D,Medeiros C R, et al. Lung transplantation [J]. Einstein (Sao Paulo), 2015, 13(2): 297-304.
[45]	Geltner C,Lass-Flörl C. Invasive pulmonary Aspergillosis in organ transplants - Focus on lung transplants [J]. Respir Investig, 2016, 54(2): 76-84.
[46]	Weigt SS,Elashoff RM,Huang C, et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome [J]. Am J Transplant, 2009, 9(8): 1903-1911.
[47]	Bhaskaran A,Mumtaz K,Husain S. Anti-aspergillus prophylaxis in lung transplantation: A systematic review and Meta-analysis [J]. Curr Infect Dis Rep, 2013, 15(6): 514-525.
[48]	Neoh CF,Snell GI,Kotsimbos T, et al. Antifungal prophylaxis in lung transplantation—A World-wide Survey [J]. Am J Transplant, 2011, 11(2): 361-366.
[49]	Patterson TF,Denning DW,Fishman JA, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America [J]. Clin Infect Dis, 2016, 63(4): 1-60.
[50]	Campos S,Caramori M,Teixeira R, et al. Bacterial and fungal pneumonias after lung transplantation [J]. Transplant Proc, 2008, 40(3): 822-824.
[51]	Schaenman JM. Is universal antifungal prophylaxis mandatory in lung transplant patients? [J]. Curr Opin Infect Dis, 2013, 26(4): 317-325.
[52]	Pilarczyk K,Haake N,Heckmann J, et al. Is universal antifungal prophylaxis mandatory in adults after lung transplantation? A review and meta-analysis of observational studies [J]. Clin Transplant 2016, 30(12): 1522-1531.
[53]	Schaenman JM. Is universal antifungal prophylaxis mandatory in lung transplant patients? [J]. Curr Opin Infect Dis, 2013, 26(4): 317-325.
[54]	Johansson I,Mårtensson G,Nyström U, et al. Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients [J]. BMC Infect Dis, 2013, 13(1): 582-592.
[55]	Santos CA,Brennan DC,Yusen RD, et al. Incidence, risk factors and outcomes of delayed-onset cytomegalovirus disease in a large retrospective cohort of lung transplant recipients [J]. Transplantation, 2015, 99(8): 1658-1666.
[56]	Paraskeva M,Bailey M,Levvey BJ, et al. Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome [J]. Am J Transplant, 2011, 11(10): 2190-2196.
[57]	Christie JD,Edwards LB,Kucheryavaya AY, et al. The registry of the international society of heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012 [J]. J Heart Lung Transplant, 2012, 31(10): 1073-1086.
[58]	Estenne M,Maurer JR,Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria [J]. J Heart Lung Transplant, 2001, 21(3): 297-310.
[59]	Snell GI,Westall GP,Levvey BJ, et al. A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation [J]. Am J Transplant, 2014, 14(5): 1191-1198.
[60]	崔向丽,宫丽丽,胡滨, 等. 肺移植术后的免疫抑制剂应用进展 [J]. 国际呼吸杂志, 2016, 36(3): 228-232.
[61]	Chen L,Gilstrap D,Cox CE. Mechanical ventilator discontinuation process [J]. Clin Chest Med, 2016, 37(4): 693-699.
[62]	Felten ML,Moyer JD,Dreyfus JF, et al. Foch Lung Transplant Group. Immediate postoperative extubation in bilateral lung transplantation: predictive factors and outcomes [J]. Br J Anaesth, 2016, 116(6): 847-854.
[63]	Van De Wauwer C,Van Raemdonck D, et al. Risk factors for airway complications within the first year after lung transplantation [J]. Eur J Cardiothorac Surg, 2007, 31(4): 703-710.
[64]	Mughal MM,Gildea TR,Murthy S, et al. Short-term deployment of self-expanding metallic stents facilitates healing of bronchial dehiscence [J]. Am J Respir Crit Care Med, 2005, 172(6): 768-771.
[65]	D′Angelo AM,Chan EG,Hayanga JW, et al. Atrial arrhythmias after lung transplantation: incidence and risk factors in 652 lung transplant recipients [J]. J Thorac Cardiovasc Surg, 2016, 152(3): 901-909.
[66]	Fan J,Zhou K,Li S, et al. Incidence, risk factors and prognosis of postoperative atrial arrhythmias after lung transplantation: a systematic review and meta-analysis [J]. Interact Cardiovasc Thorac Surg, 2016, 23(5): 790-799.
[67]	Hackman KL,Snell GI,Bach LA. Poor glycemic control is associated with decreased survival in lung transplant recipients [J]. Transplantation, 2017, 101(9): 2200-2206.

[1]	轩晨昊, 许红阳. 降钙素原对双肺移植患者术后痰培养阳性的预测价值研究[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 211-214.
[2]	董亚玲, 邓超, 刘淼淼, 张颖, 郭锋伟, 阮骊韬, 陈红, 尚佳楠, 王飞, 武慧蓉, 师桃, 宋艳. 右心室心肌应变在静脉-动脉体外膜氧合辅助支持治疗暴发性心肌炎急性期中的价值[J]. 中华危重症医学杂志(电子版), 2022, 15(04): 300-303.
[3]	苏永维, 陈果. 早产儿非心脏手术的麻醉管理[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 139-144.
[4]	中华医学会器官移植学分会肺移植学组, 国家肺移植质控中心. 新型冠状病毒感染肺移植受者选择中国专家建议[J]. 中华移植杂志(电子版), 2023, 17(01): 13-16.
[5]	惠姣洁, 梁锋鸣, 王逸峰, 王大鹏, 陈静瑜, 许红阳. 肺移植术后体外膜肺氧合流量不足处理经验[J]. 中华移植杂志(电子版), 2022, 16(04): 238-240.
[6]	吴婷, 孙燕燕, 郑媛媛, 韩威力. 支气管扩张合并强直性脊柱炎单肺移植一例[J]. 中华移植杂志(电子版), 2022, 16(04): 235-237.
[7]	刘丽欢, 刘春香, 孙红玲, 曹西霞, 曾国华. 经皮肾镜碎石取石术围术期规范化全程护理方案的构建和应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 125-132.
[8]	王桂龙, 顾正峰, 吴金波, 胡春晓, 秦钟, 张昕, 陈静瑜. 双肺移植手术室内拔管二例[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 138-140.
[9]	张付意, 侯现增, 汪建军, 辛涛. 有创颅内压监测靶向管控在重型颅脑损伤患者围术期应用价值分析[J]. 中华神经创伤外科电子杂志, 2022, 08(05): 298-301.
[10]	赵浩, 刘琛, 曲鑫, 徐跃峤, 齐猛, 陈文劲, 程玮涛, 尚峰, 蒋丽丹, 王宁. 神经外科围术期丙戊酸盐诱导高氨血症的临床研究[J]. 中华神经创伤外科电子杂志, 2022, 08(04): 218-223.
[11]	夏金根, 胡诗雨. 体外二氧化碳清除技术的重症应用场景[J]. 中华重症医学电子杂志, 2023, 09(01): 40-45.
[12]	高山, 董有静. 老年外科患者虚弱研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(03): 343-348.
[13]	许睿, 刘长红, 王蔚云, 高莹莹, 刘鸿. Roy适应模式用于Stanford B型主动脉夹层患者围术期的价值[J]. 中华临床医师杂志(电子版), 2022, 16(08): 738-743.
[14]	李宁, 刘言, 林慧庆. 肺移植供肺缺血再灌注损伤的机制及预防[J]. 中华胸部外科电子杂志, 2023, 10(04): 247-256.
[15]	方文涛. 从技术精进到理念超越——《中华胸部外科电子杂志》2022年第一期导读[J]. 中华胸部外科电子杂志, 2022, 09(02): 109-110.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Perioperative management of lung transplantation

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Perioperative management of lung transplantation